ClinConnect ClinConnect Logo
Search / Trial NCT05592301

Patent Foramen Ovale (PFO) and Risk of Perioperative Stroke

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Oct 19, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Patent Foramen Ovale Perioperative Stroke Diffusion Weighted Magnetic Resonance Imaging

ClinConnect Summary

This clinical trial is looking at whether having a condition called Patent Foramen Ovale (PFO)—a small hole in the heart that usually doesn’t cause symptoms—can increase the risk of having a stroke during or after non-heart-related surgeries. Researchers want to find out if patients with this condition are more likely to experience strokes, both obvious and subtle, when they undergo surgeries like orthopedic or gynecologic procedures.

To participate, you need to be at least 18 years old and scheduled for an elective surgery that doesn’t involve the heart or blood vessels. You should also expect to stay in the hospital for at least two days after your surgery. However, people who require long-term blood-thinning medications, have certain health issues that could raise stroke risks, or cannot have an MRI will not be eligible for the study. If you join, the study will help researchers understand better the risks associated with PFO, which could improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. patients 18 years and above;
  • 2. referred for an elective, non-cardiac, non-vascular and non-brain surgery;
  • 3. with an estimated hospital length of stay ≥2 days. We will include patients referred for general, orthopedic, urological, gynecologic, spinal or thoracic surgery.
  • Exclusion Criteria:
  • 1. patients in need for long-term, perioperative anticoagulants;
  • 2. those with comorbidities that potentially increase the risk of perioperative stroke;
  • 3. contraindications to MRI;
  • 4. unable to complete or adhere to the study.

About University Health Network, Toronto

University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Eric Horlick, MD

Principal Investigator

University Health Network, Peter Munk Cardiac Centre

Lusine Abrahamyan, MD, PhD

Principal Investigator

University Health Network, Theta Collaborative

Aleksandra Pikula, MD

Principal Investigator

University Heath Network, Division of Neurology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials